Overview
Rare infantile hemangioma refers to uncommon variants or presentations of infantile hemangiomas (IH) — benign vascular tumors composed of proliferating endothelial cells that typically appear shortly after birth. While common infantile hemangiomas affect approximately 4-5% of infants, the designation 'rare infantile hemangioma' under Orphanet (ORPHA:210589) encompasses atypical forms that may include unusual locations, morphologies, or complications that distinguish them from typical superficial or uncomplicated hemangiomas. These rare presentations may involve deep or visceral structures, segmental distributions, or multifocal disease. Infantile hemangiomas characteristically undergo a proliferative phase during the first weeks to months of life, followed by a slow involution phase that can last several years. Rare forms may affect the skin, subcutaneous tissues, liver, airway, gastrointestinal tract, or other internal organs. Key clinical features can include a rapidly growing vascular mass, ulceration, bleeding, functional impairment (such as visual obstruction when periorbital, or airway compromise in subglottic locations), and in cases of large or hepatic hemangiomas, high-output cardiac failure or consumptive hypothyroidism. Segmental hemangiomas may be associated with PHACE syndrome (posterior fossa anomalies, hemangioma, arterial anomalies, cardiac defects, and eye abnormalities) or LUMBAR syndrome. Treatment depends on the location, size, and associated complications. Oral propranolol is the first-line systemic therapy and has revolutionized management since its introduction, significantly reducing the need for surgical intervention. Topical timolol may be used for smaller, superficial lesions. In refractory or life-threatening cases, systemic corticosteroids, vincristine, or surgical excision may be considered. Laser therapy can address residual telangiectasias. Close monitoring by a multidisciplinary team including dermatology, pediatric surgery, and relevant subspecialists is recommended for rare or complicated presentations.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Rare infantile hemangioma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Rare infantile hemangioma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare infantile hemangioma.
Community
No community posts yet. Be the first to share your experience with Rare infantile hemangioma.
Start the conversation →Latest news about Rare infantile hemangioma
No recent news articles for Rare infantile hemangioma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Rare infantile hemangioma
What is Rare infantile hemangioma?
Rare infantile hemangioma refers to uncommon variants or presentations of infantile hemangiomas (IH) — benign vascular tumors composed of proliferating endothelial cells that typically appear shortly after birth. While common infantile hemangiomas affect approximately 4-5% of infants, the designation 'rare infantile hemangioma' under Orphanet (ORPHA:210589) encompasses atypical forms that may include unusual locations, morphologies, or complications that distinguish them from typical superficial or uncomplicated hemangiomas. These rare presentations may involve deep or visceral structures, seg
How is Rare infantile hemangioma inherited?
Rare infantile hemangioma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Rare infantile hemangioma typically begin?
Typical onset of Rare infantile hemangioma is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Rare infantile hemangioma?
3 specialists and care centers treating Rare infantile hemangioma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.